Peter Vozzo has held various roles in investor relations and equity research throughout his career. He currently serves as Managing Director at Westwicke. Prior to this, he worked at companies such as QIAGEN, Catalyst Health Solutions, Inc., Human Genome Sciences, and MedImmune. Peter holds an MBA in Finance/Accounting from the University of Connecticut School of Business and a B.S. in Chemistry from the University of Connecticut.